Arbutus Biopharma Corp. (ABUS)

5.095 +0.02 (+0.30%) USD  |  NASDAQ  |  Sep 01, 16:00
5.095 0.00 (0.00%) After-Hours: 19:41
More

Arbutus Biopharma Total Long Term Debt (Quarterly) : 3.111M for June 30, 2026

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for ABUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 3.111M
March 31, 2026 3.278M
December 31, 2025 3.641M
September 30, 2025 4.075M
June 30, 2025 4.485M
March 31, 2025 5.035M
December 31, 2024 5.635M
September 30, 2024 6.293M
June 30, 2024 7.003M
March 31, 2024 7.577M
December 31, 2023 8.296M
September 30, 2023 9.607M
June 30, 2023 10.43M
March 31, 2023 11.06M
December 31, 2022 12.18M
September 30, 2022 14.27M
June 30, 2022 16.32M
March 31, 2022 17.54M
December 31, 2021 18.53M
September 30, 2021 20.24M
June 30, 2021 21.46M
March 31, 2021 21.84M
December 31, 2020 22.15M
September 30, 2020 22.85M
June 30, 2020 22.61M
Date Value
March 31, 2020 22.26M
December 31, 2019 22.01M
September 30, 2019 3.143M
June 30, 2019 3.263M
March 31, 2019 3.272M
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 12.00M
September 30, 2017 12.00M
June 30, 2017 12.00M
March 31, 2017 12.00M
December 31, 2016 12.00M
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Moderna, Inc. 1.266B
Insmed, Inc. 741.01M
Pfizer Inc. 63.10B
Gossamer Bio, Inc. 39.10M
Legend Biotech Corp. 121.80M